Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring.
The new Medtronic 780G systemThe Medtronic 780G system encompasses the insulin therapy pump and the Guardian 4 constant glucose monitor — or CGM. Combined, Medtronic is able to create a hybrid closed-loop delivery system that can issue automatic corrections based on blood sugar.